These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6145533)

  • 41. Effects of prenalterol administered orally in patients with congestive heart failure.
    Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
    Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
    Bass AS; Kohli JD; Lubbers N; Goldberg LI
    J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selectivity of prenalterol for adrenergic receptor subtypes: a potential mechanism of inotropic selectivity.
    Williams RS
    J Cardiovasc Pharmacol; 1983; 5(2):266-71. PubMed ID: 6188901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prenalterol is an agonist at beta 2- as well as at beta 1-adrenoceptors.
    Apperley GH; Drew GM; Sullivan AT
    Eur J Pharmacol; 1982 Jul; 81(4):659-63. PubMed ID: 6126381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
    Mattsson H; Hedberg A; Carlsson E
    J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
    Roubin GS; Choong CY; Devenish-Meares S; Sadick NN; Fletcher PJ; Kelly DT; Harris PJ
    Circulation; 1984 May; 69(5):955-62. PubMed ID: 6142775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
    Shiu MF; Ireland MA; Littler WA
    Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct versus reflex activation of cardiac beta-adrenoceptors in the chronotropic and inotropic effects of isoprenaline and prenalterol in the conscious dog.
    Berdeaux A; Edouard A; Giudicelli JF
    J Pharmacol; 1986; 17(3):266-74. PubMed ID: 2879069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic and hormonal effects of preferential beta 1 and beta 2-adrenoceptor stimulation in man.
    Tantucci C; Santeusanio F; Beschi M; Castellano M; Sorbini C; Grassi V
    J Endocrinol Invest; 1988 Apr; 11(4):279-87. PubMed ID: 2842389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the hemodynamic effects of prenalterol and isoprenaline in patients with complete heart block.
    Svendsen TL; Pelle H; Lønholt C; Bonde J; Kampmann JP; Lindeneg O
    J Cardiovasc Pharmacol; 1984; 6(4):693-6. PubMed ID: 6206327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.
    Lambertz H; Meyer J; Erbel R
    Circulation; 1984 Feb; 69(2):298-305. PubMed ID: 6140091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative study of chronotropic and inotropic responses to 5-(-hydroxy-2-isopropylaminobutyl)-8-hydroxycarbostyril hydrochloride hemihydrade (procaterol), salbutamol, noradrenaline and isoprenaline in the dog heart.
    Chiba S
    Clin Exp Pharmacol Physiol; 1978; 5(6):601-6. PubMed ID: 31253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inotropic, chronotropic and dromotropic effects of prenalterol, a new cardiostimulant drug.
    Moore EN; Aberg G; Spear JF; Hodess AB; Herrmann I; Adler G
    Acta Med Scand Suppl; 1982; 659():53-70. PubMed ID: 6958179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
    Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
    Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rectosigmoid motility response to beta-adrenoceptor stimulation in patients with the irritable bowel syndrome.
    Lyrenäs E; Abrahamsson H; Dotevall G
    Scand J Gastroenterol; 1985 Dec; 20(10):1163-8. PubMed ID: 2869573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
    McCaffrey PM; Riddell JG; Shanks RG
    J Cardiovasc Pharmacol; 1988 May; 11(5):543-51. PubMed ID: 2455840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of a beta 1-adrenoceptor agonist, prenalterol, on renal function and renin secretion rate in anesthetized dogs.
    Johnson MD; Freese JW; Schmitt DE
    J Cardiovasc Pharmacol; 1984; 6(4):627-33. PubMed ID: 6206317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog.
    Andersson T; Heath A; Mattsson H
    Acta Med Scand Suppl; 1982; 659():71-88. PubMed ID: 6127900
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig].
    Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
    Cardiologia; 1982; 27(1):33-43. PubMed ID: 6152732
    [No Abstract]   [Full Text] [Related]  

  • 60. Basic pharmacological properties of prenalterol.
    Mattsson H; Hedberg A; Carlsson E
    Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.